EMERALD ADVISERS, LLC - ZIOPHARM ONCOLOGY INC ownership

ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 133 filers reported holding ZIOPHARM ONCOLOGY INC in Q1 2015. The put-call ratio across all filers is 0.78 and the average weighting 0.5%.

Quarter-by-quarter ownership
EMERALD ADVISERS, LLC ownership history of ZIOPHARM ONCOLOGY INC
ValueSharesWeighting
Q3 2016$69,000
-97.7%
12,307
-97.8%
0.00%
-97.9%
Q2 2016$3,028,000
-26.2%
551,521
-0.2%
0.15%
-27.0%
Q1 2016$4,101,000
-14.7%
552,751
-4.5%
0.20%
-11.9%
Q4 2015$4,810,000
+8.1%
578,805
+17.2%
0.23%
-2.2%
Q3 2015$4,451,000
-26.2%
493,966
-1.8%
0.23%
-19.4%
Q2 2015$6,033,000
+79.3%
502,770
+37.8%
0.29%
+70.4%
Q1 2015$3,364,000
+151.8%
364,808
+38.4%
0.17%
+138.0%
Q4 2014$1,336,000
+18985.7%
263,508
+14872.0%
0.07%
Q2 2014$7,0001,7600.00%
Other shareholders
ZIOPHARM ONCOLOGY INC shareholders Q1 2015
NameSharesValueWeighting ↓
MSD Partners, L.P. 10,986,258$20,544,0001.80%
Third Security, LLC 4,364,080$8,161,0001.11%
MILLER VALUE PARTNERS, LLC 9,264,700$16,617,0000.75%
Sargent Investment Group, LLC 188,950$353,0000.22%
Chessman Wealth Strategies RIA 72,050$135,0000.14%
Ibex Investors LLC 403,650$755,0000.12%
Old West Investment Management, LLC 223,319$417,0000.11%
PIPER SANDLER & CO. 34,222$64,0000.07%
Virtus ETF Advisers LLC 102,888$192,0000.03%
G&S Capital LLC 18,000$34,0000.03%
View complete list of ZIOPHARM ONCOLOGY INC shareholders